Literature DB >> 18030039

Scintigraphic visualization of glossal thyroid tissue during the follow-up of thyroid cancer patients.

Paolo Zanotti-Fregonara1, Elif Hindié, Isabelle Keller, Marie Calzada-Nocaudie, Jean-Yves Devaux.   

Abstract

PURPOSE: Nests of thyroid tissue in the tongue are described in about 10% of necropsies. This ectopic thyroid tissue usually lies dormant, but may manifest itself during times of increased stimulation. The aim of our study was to assess the frequency of lingual thyroid visualization on I-131 diagnostic whole-body scan during the follow-up of thyroid cancer patients.
MATERIAL AND METHODS: We reviewed the files of 548 consecutive patients who underwent a diagnostic whole-body scan with 200 MBq of I-131 between January 2000 and December 2005, as part of the follow-up for a differentiated thyroid cancer. Every patient had been previously treated with a total thyroidectomy and had received 3.7 GBq (100 mCi) of I-131 for remnant ablation.
RESULTS: A focus of uptake located between the 2 submandibular salivary glands, suggestive of ectopic thyroid tissue in the tongue or in the upper part of the thyroglossal duct, was found in 5 of the 548 patients (0.9%). In only one of these patients was the uptake visible at the time of postsurgery thyroid remnant ablation scan. Thyroglobulin (Tg) levels were positive under stimulation in 3 of the 5 patients, and another patient had undetectable Tg, but positive anti-Tg antibodies. Radiologic imaging (MRI and/or ultrasound) was performed in 3 patients and confirmed the presence of a mass suggestive of ectopic thyroid tissue in two. Invasive lingual biopsy was not performed to verify the benign nature.
CONCLUSION: When examining whole-body scans (therapeutic or diagnostic) in a patient with persistent Tg detection after thyroid ablation, one should carefully search for any uptake between the submandibular glands that may be suggestive of ectopic tissue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18030039     DOI: 10.1097/RLU.0b013e31815976f6

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  3 in total

1.  A low thyroglobulin level cannot be used to avoid adjuvant 131I therapy after thyroidectomy for thyroid carcinoma.

Authors:  Paolo Zanotti-Fregonara; Gaia Grassetto; Elif Hindié; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-02       Impact factor: 9.236

2.  Retrospective imaging study on the diagnosis of pathological false positive iodine-131 scans in patients with thyroid cancer.

Authors:  Qiang Jia; Zhaowei Meng; Jian Tan; Guizhi Zhang; Yajing He; Haoran Sun; Chunshui Yu; Dong Li; Wei Zheng; Renfei Wang; Shen Wang; Xue Li; Jianping Zhang; Tianpeng Hu; N A Liu; Arun Upadhyaya
Journal:  Exp Ther Med       Date:  2015-09-11       Impact factor: 2.447

3.  Rate of thyroglossal duct remnant visualization after total thyroidectomy for differentiated thyroid carcinoma and its impact on clinical outcome of radioactive iodine (I-131) ablation.

Authors:  Mohamed Hosny Mohamed Sayed; Hussein Rabie Saleh Farghaly; Fahd Ahmad Fadl
Journal:  Indian J Nucl Med       Date:  2015 Apr-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.